The group’s principal activity is to develop vaccines for cancer, infectious diseases and viral maladies. The group’s products include preventative and therapeutic vaccines, immunotherapies, and biodefense applications. The group operates from the United States.
Executive Information
Name
Title
Email
Jonathan Smith
Chief Scientific Officer, Member - Science, Advisory Board